Reduced neuronal efficacy in progressive mild cognitive impairment: a prospective fMRI study on visuospatial

Patrizia Vannini1, Ove Almkvist, Thomas Dierks

  • 1Department of Neurobiology, Care Sciences and Society, Division of Clinical Geriatrics, Karolinska Institutet, Karolinska University Hospital, Huddinge, 141 86 Stockholm, Sweden. Patrizia.Vannini@ki.se

Psychiatry Research
|August 28, 2007
PubMed

Insights

Brain imaging in mild cognitive impairment (MCI) detected altered brain function in individuals who progressed to Alzheimer's disease (AD) before behavioral symptoms emerged. Increased parietal activation may predict future cognitive decline.

Area of Science:

  • Neuroscience
  • Cognitive Neurology
  • Medical Imaging

Background:

  • Mild cognitive impairment (MCI) is often a preclinical stage of Alzheimer's disease (AD).
  • Neurodegenerative changes and compensatory mechanisms may precede overt clinical symptoms of AD.
  • Identifying early biomarkers is crucial for timely intervention in AD progression.

Purpose of the Study:

  • To investigate brain region functioning in visuospatial networks related to preclinical AD symptoms.
  • To utilize event-related functional magnetic resonance imaging (fMRI) to detect alterations in MCI patients.
  • To correlate brain activity with task demands and individual performance.

Main Methods:

  • Prospective study of 18 MCI patients (5 progressing to AD [PMCI], 8 stable [SMCI]) and 13 controls.
  • Event-related fMRI during an angle discrimination task with varying demands.
  • Analysis using an extended general linear model incorporating reaction time (RT) for single trials.

Main Results:

  • No significant behavioral differences (RT, accuracy) were found between MCI patients and controls.
  • A bilateral activation network, including the dorsal pathway, increased linearly with task demand in all groups.
  • PMCI patients exhibited a stronger task demand-brain activity relationship in the left superior parietal lobules (SPL) and increased task-independent activation in the left precuneus compared to SMCI and controls.

Conclusions:

  • Altered brain function is detectable at a group level in individuals progressing to AD before behavioral changes are apparent.
  • Increased parietal activation in PMCI may indicate reduced neuronal efficacy due to AD pathology.
  • These findings suggest potential predictive value for future clinical decline in MCI patients.

Related Concept Videos